deals done......deals to come, page-6

Tangent I feel as though I've just been on speed date with Phosphagenics.

So many beauties but not enough money to take em all out and really get to know them.

Could that actually be a reason as to why the market has us sitting at 13c?

Are we now perceived to be too diversified to be taken seriously? I wonder.

As a long time holder and AGM attendee I'm aware that management are concentrating on commercializing oxy. Esra said so.

However if one only took to reading the announcements and the new never ending TPM applications one could end up thinking quite differently about this company's focus and where it's limited cash is going.

If we want the SP to move we need to attract new investors and the best way to do that is to be taken seriously by doing a nice commercial deal.

We've all been saying it for years.